HCV-IN-7 is a potent, orally bioavailable pan-genotypic HCV NS5A inhibitor with picomolar activity (IC50s: 3-47 pM). It exhibits favorable pharmacokinetics and liver distribution, making it a valuable tool compound for antiviral mechanism studies and in vitro/vivo efficacy research across all major HCV genotypes.
Molecular Weight:
768.92
CAS Number:
[1449756-86-8]
Formula:
C40H48N8O6S
Target:
HCV Protease,Others
* VAT and and shipping costs not included. Errors and price changes excepted